inflammation therapy (Synolgic)

N/A

Report date: 2025/03/20 15:31:10
NME

Base Information

Drug Nameinflammation therapy (Synolgic)
Drug Alias Namemicrobiome modulator (Synlogic)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynlogic Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynlogic Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A